GlaxoSmithKline reported 18.52B in Current Assets for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 21299M 155M
Artemis Alpha ATS:LN 868K 5.59M
AstraZeneca AZN:LN 18.74B 809M
Bayer BAYN:GR 35.66B 3.68B
Biogen BIIB:US $ 6719.5M 167.6M
Bristol Myers Squibb BMY:US $ 27111M 3081M
Eli Lilly And LLY:US $ 16604.5M 857.6M
Fresenius FRE:GR € 16693M 921M
Fresenius Medical Care FME:GR € 7789M 513.69M
Galapagos GLPG:NA 5.31B 58.42M
Genmab GEN:DC 19.94B 1.15B
Gilead Sciences GILD:US $ 13166M 2830M
GlaxoSmithKline GSK:LN 18.52B 1.72B
Glaxosmithkline GSK:US $ 18524M 1723M
GRIFOLS GRF:SM € 3164.95M 478.66M
H. Lundbeck A/S LUN:DC 10.1B 240M
Hikma Pharmaceutical HIK:LN 1.92B 44M
Novartis NOVN:VX 22.2B 7.48B
Orion ORNBV:FH 779.1M 35.4M
Recordati REC:IM 861.32M 88.37M
Regeneron Pharmaceuticals REGN:US $ 10055.1M 276M